ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

Serial Number 87784530
606

Registration Progress

Application Filed
Feb 5, 2018
Under Examination
Mar 19, 2019
Approved for Publication
Jan 22, 2019
Published for Opposition
Jan 22, 2019
Registered

Trademark Image

ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

Basic Information

Serial Number
87784530
Filing Date
February 5, 2018
Published for Opposition
January 22, 2019
Abandonment Date
April 19, 2021
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 19, 2021
Classes
005

Rights Holder

Aerie Pharmaceuticals, Inc.

03
Address
2030 Main Street
Suite 1500
Irvine, CA 92688

Ownership History

Aerie Pharmaceuticals, Inc.

Original Applicant
03
Irvine, CA

Aerie Pharmaceuticals, Inc.

Owner at Publication
03
Irvine, CA

Legal Representation

Attorney
Melissa W. Woo-Allen

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Apr 19, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 19, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 15, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 11, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 11, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 14, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 12, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 12, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 12, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 9, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 8, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 8, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 21, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 21, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 21, 2019 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Oct 21, 2019 PETG O PETITION TO REVIVE-GRANTED Loading...
Oct 21, 2019 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Oct 21, 2019 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Sep 19, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 19, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 22, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 2, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 12, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 12, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 12, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 4, 2018 ALIE A ASSIGNED TO LIE Loading...
Nov 28, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 28, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 28, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 28, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 18, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 14, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 13, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 8, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the word "RHOPRESSA" with a half circle above and beneath the "RHO" portion of the word "RHOPRESSA" and the word "ONCE-DAILY" above "RHOPRESSA" and the words "(NETARSUDIL OPHTHALMIC SOLUTION) 0.02%" beneath "RHOPRESSA".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ONCE-DAILY", "NETARSUDIL OPHTHALMIC SOLUTION 0.02%"